Skip to content
Screener

EyePoint, Inc. EYPT Return on equity

Return on equity at other companies

Merck & Co. logo
Merck & Co.MRK
7%-28.5pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
14%-1.3pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-68.6%+17.0pp
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-208.8%+2,306pp
Regenxbio logo
RegenxbioRGNX
-137.6%-817pp
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-45.4%+29.8pp

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.11B+51.9%
Enterprise value$1.02B+49.6%
P/S396.6×+383×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Calculated from EyePoint, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037

FAQ

What is EyePoint, Inc.'s return on equity?
EyePoint, Inc. (EYPT) reported return on equity of -148.7% in Q2 2026.
How has EyePoint, Inc.'s return on equity changed year-over-year?
EyePoint, Inc.'s return on equity decreased by 101.1% year-over-year, from -74% to -148.7%.
What is the long-term trend for EyePoint, Inc.'s return on equity?
Over 5 years (2020 to 2025), EyePoint, Inc.'s return on equity has grown at a -26.6% compound annual growth rate (CAGR), from -337.9% to -72.2%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about EyePoint, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude